Exhibit 107
Calculation of Filing Fee Tables
Form 424(b)(5)
(Form Type)
Verve Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee(2) | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward | |||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||
| Fees to Be Paid | Equity | Common Stock, $0.001 par value per share | 457(r) | 14,375,000 | $10.00 | $143,750,000 | 0.0001476 | $21,217.50 | — | — | — | — | ||||||||||||
| Fees Previously Paid | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||
| Carry Forward Securities | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||
| Total Offering Amounts | $143,750,000 | $21,217.50 | ||||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | $21,217.50 | |||||||||||||||||||||||
| (1) | Assumes exercise in full of the underwriters’ option to purchase up to 1,875,000 additional shares of common stock. |
| (2) | In accordance with Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). This “Calculation of Filing Fee Tables” table shall be deemed to update the table in Item 14 in the registrant’s Registration Statement on Form S-3 (File No. 333-267578) in accordance with Rule 456(b) and 457(r) under the Securities Act. |
